• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
prison reform

Critically Ill Prisoner Had Sentence Reduced Under Trump’s ‘Compassionate Release’ Program

By
Renae Reints
Renae Reints
Down Arrow Button Icon
By
Renae Reints
Renae Reints
Down Arrow Button Icon
March 15, 2019, 4:18 PM ET

A man from Houston, Texas became among the first federal prisoners to benefit from the “compassionate release” program expanded under President Donald Trump’s 2018 First Step Act this week when he was let go to receive medical treatment.

Richard Evans, 74, was just under two years into a five-year sentence for conspiracy, fraud, and distributing prescription narcotics when he noticed a mass growing on his neck, NPR reports. After the Federal Bureau of Prisons denied his initial request for release, Evans took his case to a judge.

Under the compassionate release program, elderly and ill prisoners can petition a judge for early release if the BOP fails to act on their case within 30 days. The inmate must prove their health is in severe condition, requiring treatment outside of the prison system.

U.S. District Judge Kenneth Hoyt, who initially sentenced Evans in 2017, found that the former doctor had “extraordinary and compelling reasons” to be released, NPR reports. Evans sentence was reduced to the time he had already served, plus three years of supervised release.

Despite the fact the judge acted within days of Evans’ request, the mass of malignant melanoma on his neck had swelled to 5 inches since he first reported his health concern to officials in October of last year. Evans was released Thursday from the Louisiana prison where he was serving his sentence and returned to Houston, where he will see experts at the MD Anderson Cancer Center next week, says NPR.

About the Author
By Renae Reints
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.